Bio-Techne noted that the launch represents the re-branding of the previously acquired CyPlex instrument platform from CyVek.

The Simple Plex platform is an immunoassay technology, which incorporates microfluidic cartridge with a state-of-the-art analyzer to deliver efficient benchtop immunoassay system along with reliable results.

Bio-Techne president and CEO Chuck Kummeth said: "Meeting our customers’ expectations during their workflow is consistent with our long term goal of providing increasingly more complete workflow solutions to investigators.

"The ability to include the highly valued Bio-Techne reagent content on the Simple Plex platform, along with our assay development know-how, is one of the most appealing aspects of this technology."

The platform is said to offer a level of automation to the traditional ELISA by providing "sample-to-answer" test results in a sealed disposable cartridge within, while removing operator related biases.

In addition, the platform can be used in both research and clinical markets, due its multi-analyte capability.

The Simple Plex platform is said to complement other instrument platforms, including instruments for automated Western blot analysis, devices for isoelectric focusing of proteins and protein particle analysis.

ProteinSimple will manufacture and further develop Simple Plex platform, and will leverage the extensive reagent portfolio from Bio-Techne.

Image: Anti human IgG" Double Antibody Sandwich ELISA. Photo: courtesy of BiotechMichael.